Health Catalyst Inc (HCAT)
NASDAQ: HCATTechnologyComputer Software: Programming Data ProcessingUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
HCAT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $99.76M
- EPS (TTM)
- -$2.80
- Dividend yield
- None
- 52-week range
- 0.955 – 3.03
- Day range
- 1.27 – 1.38
- Volume / Avg
- 711.63K / 414.24K
- Beta
- —
- Shares outstanding
- 76.16M
52-week range
HCAT stock today
Health Catalyst (HCAT) closed at $1.31 on Nov 20, up 1.55% (+$0.02), versus the S&P 500's 3.70% decline. At this level, HCAT sits near the bottom of its 52-week range of $0.955 to $3.03: 56.7% below the high, set on Nov 28, 2025 and 37.2% above the low. HCAT is down 45.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 44.5%.
Health Catalyst has posted a net loss over the last twelve months (EPS of -$2.80), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Health Catalyst
Company profileHealth Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services.
- Sector
- Technology
- Industry
- Computer Software: Programming Data Processing
- CEO
- Mr. Simeon M. Kohl
- Headquarters
- South Jordan, UT
- Employees
- 1,200
- IPO year
- 2019
- Website
- healthcatalyst.com
Financial highlights
Full financialsIn fiscal 2025, Health Catalyst generated $311.1 million in revenue, up 1.5% from fiscal 2024, its 8th consecutive year of revenue growth. Health Catalyst reported a net loss of $178.0 million, compared with a loss of $69.5 million a year earlier. Gross margin was 48.7% (up from 45.9%) and operating margin -51.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $311.14M | $306.58M | $295.94M | $276.24M | $241.93M |
| Growth | +1.48% | +3.60% | +7.13% | +14.18% | +28.11% |
| Net income | $-177.97M | $-69.50M | $-118.15M | $-137.40M | $-153.21M |
| EPS (diluted) | $-2.55 | $-1.15 | $-2.09 | $-2.63 | $-3.23 |
Analyst forecast
ForecastConsensus (5 analysts)
hold
Avg. price target
$1.77+35.11%
- Strong buy 0
- Buy 1
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.53 vs $-0.07
- Surprise
- +857.14%
HCAT news
All HCAT newsHealth Catalyst peers
Technology sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DOYUDouYu International Holdings Limited ADS | 3.25 | +3.50% | $98.08M | vs HCAT |
| DSCDSC Holdings Ltd. ADR | 1.91 | -5.91% | $95.64M | vs HCAT |
| GMMGlobal Mofy AI Limited Class A | 1.39 | -27.60% | $80.27M | vs HCAT |
| PODCPodcastOne Inc. | 1.79 | -2.19% | $56.04M | vs HCAT |
| SANGSangoma Technologies Corporation | 4.63 | -1.91% | $155.22M | vs HCAT |
| SOGPSound Group Inc. ADR | 8.13 | -13.51% | $34.06M | vs HCAT |
| JGAurora Mobile Limited ADR | 5.91 | -1.17% | $33.89M | vs HCAT |
| GOAIEva Live Inc. | 0.5242 | +1.96% | $21.56M | vs HCAT |
Indexes, lists and sector
Appears in lists
Largest Technology stocks
Health Catalyst stock FAQ
What is Health Catalyst's stock price today?
HCAT last traded at $1.31 as of Nov 20, 4:00 PM EST, up 1.55% on the day. Prices are delayed at least 15 minutes.
Who is Health Catalyst's CEO?
Mr. Simeon M. Kohl is the chief executive officer of Health Catalyst Inc, which has about 1,200 employees.
What is the HCAT 52-week high?
The 52-week high for HCAT is $3.03 and the 52-week low is $0.955. The stock is currently 56.7% below its high.